Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-19

Clinical Trial Update: Budesonide for Mycophenolic Acid-induced Diarrhea in Renal Transplant Recipients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating budesonide for mycophenolic acid-induced diarrhea in renal transplant recipients; the study was terminated and results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Budesonide (BUDESONIDE)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Diarrhea | Phase 2 | Status: TERMINATED | Results posted: 2024-09-19